We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+12.74%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.61B
AUM Growth
+$133M
Cap. Flow
-$26.6M
Cap. Flow %
-1.65%
Top 10 Hldgs %
30.12%
Holding
615
New
127
Increased
127
Reduced
202
Closed
76
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVE icon
101
iShares S&P 500 Value ETF
IVE
$48.5B
$3.41M 0.21%
30,251
-50
-0.2% -$5.49K
GBT
102
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.38M 0.21%
63,900
+9,000
+16% +$442K
EA icon
103
Electronic Arts
EA
$52.4B
$3.38M 0.21%
33,252
+8,602
+35% +$815K
OEF icon
104
iShares S&P 100 ETF
OEF
$19.8B
$3.37M 0.21%
26,864
CTSH icon
105
Cognizant
CTSH
$20.3B
$3.24M 0.2%
44,715
+4,800
+12% +$336K
LEA icon
106
Lear
LEA
$7.14B
$3.23M 0.2%
23,837
-248
-1% -$36.4K
GILD icon
107
Gilead Sciences
GILD
$162B
$3.22M 0.2%
49,565
+5,929
+14% +$394K
CFG icon
108
Citizens Financial Group
CFG
$30.3B
$3.22M 0.2%
99,071
-11,300
-10% -$392K
CELG
109
DELISTED
Celgene Corp
CELG
$3.19M 0.2%
33,774
+830
+3% +$72.6K
NXPI icon
110
NXP Semiconductors
NXPI
$70B
$3.16M 0.2%
35,745
+4,270
+14% +$375K
IVW icon
111
iShares S&P 500 Growth ETF
IVW
$72.9B
$3.11M 0.19%
72,152
-2,968
-4% -$122K
VKTX icon
112
Viking Therapeutics
VKTX
$4.11B
$3.1M 0.19%
312,200
+163,200
+110% +$1.37M
BAC icon
113
Bank of America
BAC
$430B
$3.09M 0.19%
111,879
+9,889
+10% +$279K
ARWR icon
114
Arrowhead Research
ARWR
$12.2B
$3.04M 0.19%
165,600
+55,600
+51% +$917K
ARNA
115
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3M 0.19%
67,000
+18,000
+37% +$826K
WH icon
116
Wyndham Hotels & Resorts
WH
$5.5B
$2.99M 0.19%
59,813
+306
+0.5% +$15.5K
LIN icon
117
Linde
LIN
$234B
$2.96M 0.18%
16,809
+11
+0.1% +$1.83K
IGF icon
118
iShares Global Infrastructure ETF
IGF
$10.9B
$2.94M 0.18%
65,525
+2,230
+4% +$95.6K
VPU
119
Vanguard Utilities ETF
VPU
$8.83B
$2.92M 0.18%
22,570
-289
-1% -$35.8K
CBAY
120
DELISTED
Cymabay Therapeutics
CBAY
$2.86M 0.18%
215,100
+90,100
+72% +$958K
CMI icon
121
Cummins
CMI
$91.8B
$2.85M 0.18%
18,080
+381
+2% +$57.2K
RWX icon
122
State Street SPDR Dow Jones International Real Estate ETF
RWX
$262M
$2.82M 0.18%
71,857
-2,052
-3% -$78.2K
GVI icon
123
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
$2.79M 0.17%
25,305
+5,357
+27% +$583K
PYPL icon
124
PayPal
PYPL
$49.4B
$2.77M 0.17%
26,692
+19,900
+293% +$1.88M
SCHF icon
125
Schwab International Equity ETF
SCHF
$65.7B
$2.77M 0.17%
176,736
-13,170
-7% -$201K

Similar funds

Bailard's Q1 2019 Portfolio in Review

As of Q1 2019, Bailard held 615 positions worth $1.61B, up 9% from $1.48B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bailard's Q1 2019 filing shows 127 new, 127 increased, 202 reduced and 76 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 293,591 shares worth $7.41M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $56.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

  • Bailard's largest Q1 2019 buy was iShares US Treasury Bond ETF: 293,591 shares worth $7.41M.
  • Bailard added most to Invesco QQQ Trust in Q1 2019, an estimated $53.3M increase.
  • Bailard's biggest Q1 2019 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $56.4M.
  • Bailard fully exited State Street SPDR Portfolio Long Term Treasury ETF in Q1 2019, selling an estimated $1.65M.
  • Bailard's ten largest holdings make up 30% of its $1.61B portfolio in Q1 2019.
  • Bailard opened 127 new positions and closed 76 in Q1 2019.
  • Bailard's portfolio value rose 9% quarter-over-quarter to $1.61B.

Based on Bailard's 13F filing for Q1 2019, filed 24 Apr 2019.